These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20144328)

  • 21. Screening for diabetes mellitus--a two-step approach in individuals with impaired fasting glucose improves detection of those at risk of complications.
    Tai ES; Lim SC; Tan BY; Chew SK; Heng D; Tan CE
    Diabet Med; 2000 Nov; 17(11):771-5. PubMed ID: 11131101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating Concentrations of Advanced Glycation end Products, its Association With the Development of Diabetes Mellitus.
    Jiménez IU; Díaz-Díaz E; Castro JS; Ramos JP; León MC; Alvarado Ríos JA; Auriostigue Bautista JC; Correa-Rotter R; Aguilar Salinas CA; Larrea F
    Arch Med Res; 2017 May; 48(4):360-369. PubMed ID: 29157674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skin autofluorescence (a marker for advanced glycation end products) and erectile dysfunction in diabetes.
    Kouidrat Y; Zaitouni A; Amad A; Diouf M; Desailloud R; Loas G; Lalau JD
    J Diabetes Complications; 2017 Jan; 31(1):108-113. PubMed ID: 27847146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetes.
    Sell DR; Sun W; Gao X; Strauch C; Lachin JM; Cleary PA; Genuth S; ; Monnier VM
    Cardiovasc Diabetol; 2016 Feb; 15():30. PubMed ID: 26864236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accumulation of Advanced Glycation Endproducts and Subclinical Inflammation in Deep Tissues of Adult Patients With and Without Diabetes.
    Hu H; Jiang H; Zhu L; Wu X; Han C
    Can J Diabetes; 2018 Oct; 42(5):525-532.e4. PubMed ID: 29803627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incretin hormones, insulin, glucagon and advanced glycation end products in relation to cognitive function in older people with and without diabetes, a population-based study.
    Dybjer E; Engström G; Helmer C; Nägga K; Rorsman P; Nilsson PM
    Diabet Med; 2020 Jul; 37(7):1157-1166. PubMed ID: 32020688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes.
    Genuth S; Sun W; Cleary P; Sell DR; Dahms W; Malone J; Sivitz W; Monnier VM;
    Diabetes; 2005 Nov; 54(11):3103-11. PubMed ID: 16249432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.
    Adam JM; Tarigan NP
    Acta Med Indones; 2004; 36(1):3-7. PubMed ID: 15931695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effects of Taurine Supplementation on Metabolic Profiles, Pentosidine, Soluble Receptor of Advanced Glycation End Products and Methylglyoxal in Adults With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Esmaeili F; Maleki V; Kheirouri S; Alizadeh M
    Can J Diabetes; 2021 Feb; 45(1):39-46. PubMed ID: 32861603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study.
    Franciosi M; De Berardis G; Rossi MC; Sacco M; Belfiglio M; Pellegrini F; Tognoni G; Valentini M; Nicolucci A
    Diabetes Care; 2005 May; 28(5):1187-94. PubMed ID: 15855587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review.
    Fishman SL; Sonmez H; Basman C; Singh V; Poretsky L
    Mol Med; 2018 Nov; 24(1):59. PubMed ID: 30470170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of the diabetes screening tools proposed by the American Diabetes Association in an aging Chinese population.
    Woo YC; Lee CH; Fong CHY; Tso AWK; Cheung BMY; Lam KSL
    PLoS One; 2017; 12(9):e0184840. PubMed ID: 28910380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of skin autofluorescence as a marker of advanced glycation end product accumulation in type 1 diabetes.
    Samborski P; Naskręt D; Araszkiewicz A; Niedźwiecki P; Zozulińska-Ziółkiewicz D; Wierusz-Wysocka B
    Pol Arch Med Wewn; 2011 Mar; 121(3):67-72. PubMed ID: 21430607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of protein glycation in human fingernail clippings with near-infrared (NIR) spectroscopy as an alternative technique for the diagnosis of diabetes mellitus.
    Monteyne T; Coopman R; Kishabongo AS; Himpe J; Lapauw B; Shadid S; Van Aken EH; Berenson D; Speeckaert MM; De Beer T; Delanghe JR
    Clin Chem Lab Med; 2018 Aug; 56(9):1551-1558. PubMed ID: 29750643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dermal microvessel density and maturity is closely associated with atherogenic dyslipidemia and accumulation of advanced glycation end products in adult patients with type 1 diabetes.
    Adamska A; Araszkiewicz A; Pilacinski S; Gandecka A; Grzelka A; Kowalska K; Malinska A; Nowicki M; Zozulinska-Ziolkiewicz D
    Microvasc Res; 2019 Jan; 121():46-51. PubMed ID: 30312628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes Mellitus: Screening and Diagnosis.
    Pippitt K; Li M; Gurgle HE
    Am Fam Physician; 2016 Jan; 93(2):103-9. PubMed ID: 26926406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skin fluorescence as a clinical tool for non-invasive assessment of advanced glycation and long-term complications of diabetes.
    Fokkens BT; Smit AJ
    Glycoconj J; 2016 Aug; 33(4):527-35. PubMed ID: 27287226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Non-enzymatic glycation of proteins: from diabetes to cancer].
    Ansari NA; Rasheed Z
    Biomed Khim; 2010; 56(2):168-78. PubMed ID: 21341505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of advanced glycated end product accumulation in skin using auto fluorescence multispectral imaging.
    Larsson M; Favilla R; Strömberg T
    Comput Biol Med; 2017 Jun; 85():106-111. PubMed ID: 27106500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End-Products, Is Associated With Prevalent Vertebral and Major Osteoporotic Fractures: The Rotterdam Study.
    Waqas K; Chen J; Koromani F; Trajanoska K; van der Eerden BC; Uitterlinden AG; Rivadeneira F; Zillikens MC
    J Bone Miner Res; 2020 Oct; 35(10):1904-1913. PubMed ID: 32463533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.